Autopsy report · NCT02731144
Optimized Caloric-proteic Nutrition in Septic and Septic Shock Patients
Cause of deathOther
“The protocol was modified substantially and will be resubmitted to Clinical Trial”
Life of this trial
- Registered 2 months before it started.
- Ran for about 1 year 8 months before it stopped.
- 10 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Hospital Sao Domingos
- Sponsor type
- University, hospital or other
- Conditions
- Sepsis; Septic Shock
- Interventions
- Peptamen intense; Novasource senior
- Participants
- 10
Trials that died the same way
- BreathID Multi-center HCV Liver Breath Test Study
“Due to FDA comments, protocol changed; new trial will be proposed shortly” - Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.
“Initial version of the protocol not submitted and new version approved has a new sponsor and it has been added into Clinicaltrials by the new sponsor” - A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma
“Replaced with another clinical trial.” - Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study
“study revised and reinitiated under another protocol” - Saracatinib in Treating Patients With Prostate Cancer
“Per protocol, study was terminated due to low rate of randomized patients.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.